Volume 44, Issue 32
21 August 2023
Cover image
Cover image
Intravenous thrombolysis for bioprosthetic valve thrombosis.
ISSN 0195-668X
EISSN 1522-9645
Issue navigation
Volume 44, Issue 32, 21 August 2023
Focus Issue on Thrombosis and Antithrombotic Treatment
Issue @ A Glance
Antithrombotic treatment: personalized antiplatelet therapies and lessons from the gut microbiota
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3023–3026, https://doi.org/10.1093/eurheartj/ehad521
CardioPulse
Are we ready for cell-specific therapies in atherosclerosis?
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3027–3030, https://doi.org/10.1093/eurheartj/ehad147
Investigator Nazha Hamdani MD, PhD, talks to CardioPulse about her love of science and why we may be closer than we think to unravelling a clinical conundrum
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3031–3033, https://doi.org/10.1093/eurheartj/ehad311
Implementation of a national primary percutaneous coronary intervention program for ST-segment elevation myocardial infarction in the Kingdom of Bahrain: an inspiring success story from a centre of excellence
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3034–3037, https://doi.org/10.1093/eurheartj/ehad329
Weekly Journal Scan
Heart failure and socioeconomic status: global differences and inequalities
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3038–3039, https://doi.org/10.1093/eurheartj/ehad410
Special Article
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3040–3058, https://doi.org/10.1093/eurheartj/ehad388
State of the Art Review
Personalised antiplatelet therapies for coronary artery disease: what the future holds
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3059–3072, https://doi.org/10.1093/eurheartj/ehad362
Meta-analysis
Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3073–3081, https://doi.org/10.1093/eurheartj/ehad417
Editorial
A novel prediction model for pulmonary embolism: from dichotomizing algorithms to personalized likelihood
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3082–3084, https://doi.org/10.1093/eurheartj/ehad392
Clinical Research
Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3085–3096, https://doi.org/10.1093/eurheartj/ehad333
Editorial
A roadmap for gut microbiome-derived aromatic amino acids for improved cardiovascular risk stratification
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3097–3099, https://doi.org/10.1093/eurheartj/ehad367
Discussion Forum
Comparison of bleeding risk between standard ticagrelor and prasugrel therapies without de-escalation strategy
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3100–3101, https://doi.org/10.1093/eurheartj/ehad432
Comparison of standard ticagrelor and prasugrel therapies based on previous trials
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Pages 3102–3103, https://doi.org/10.1093/eurheartj/ehad433
Cardiovascular Flashlight
Intravenous thrombolysis for bioprosthetic valve thrombosis
European Heart Journal, Volume 44, Issue 32, 21 August 2023, Page 3104, https://doi.org/10.1093/eurheartj/ehad303
